for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-NCCN Guidelines Recommend Novocure's Optune In Combination With Temozolomide

March 20 (Reuters) - Novocure Ltd:

* NCCN GUIDELINES RECOMMEND OPTUNE IN COMBINATION WITH TEMOZOLOMIDE AS A CATEGORY 1 TREATMENT FOR NEWLY DIAGNOSED GLIOBLASTOMA

* NOVOCURE - NCCN UPDATED CLINICAL PRACTICE GUIDELINES TO RECOMMEND OPTUNE IN COMBINATION WITH TEMOZOLOMIDE AS CATEGORY 1 TREATMENT FOR NEWLY DIAGNOSED GBM Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up